Literature DB >> 9649583

Interactions of a reversible ryanoid (21-amino-9alpha-hydroxy-ryanodine) with single sheep cardiac ryanodine receptor channels.

B Tanna1, W Welch, L Ruest, J L Sutko, A J Williams.   

Abstract

The binding of ryanodine to a high affinity site on the sarcoplasmic reticulum Ca2+-release channel results in a dramatic alteration in both gating and ion handling; the channel enters a high open probability, reduced-conductance state. Once bound, ryanodine does not dissociate from its site within the time frame of a single channel experiment. In this report, we describe the interactions of a synthetic ryanoid, 21-amino-9alpha-hydroxy-ryanodine, with the high affinity ryanodine binding site on the sheep cardiac sarcoplasmic reticulum Ca2+-release channel. The interaction of 21-amino-9alpha-hydroxy-ryanodine with the channel induces the occurrence of a characteristic high open probability, reduced-conductance state; however, in contrast to ryanodine, the interaction of this ryanoid with the channel is reversible under steady state conditions, with dwell times in the modified state lasting seconds. By monitoring the reversible interaction of this ryanoid with single channels under voltage clamp conditions, we have established a number of novel features of the ryanoid binding reaction. (a) Modification of channel function occurs when a single molecule of ryanoid binds to the channel protein. (b) The ryanoid has access to its binding site only from the cytosolic side of the channel and the site is available only when the channel is open. (c) The interaction of 21-amino-9alpha-hydroxy-ryanodine with its binding site is influenced strongly by transmembrane voltage. We suggest that this voltage dependence is derived from a voltage-driven conformational alteration of the channel protein that changes the affinity of the binding site, rather than the translocation of the ryanoid into the voltage drop across the channel.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649583      PMCID: PMC2229406          DOI: 10.1085/jgp.112.1.55

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  39 in total

1.  Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.

Authors:  I N Pessah; I Zimanyi
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

2.  Ryanodine receptor type III (Ry3R) identification in mouse parotid acini. Properties and modulation of [3H]ryanodine-binding sites.

Authors:  D H DiJulio; E L Watson; I N Pessah; K L Jacobson; S M Ott; E D Buck; J C Singh
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

3.  Calcium efflux from a heavy sarcotubular fraction. Effects of ryanodine, caffeine and magnesium.

Authors:  A S Fairhurst; W Hasselbach
Journal:  Eur J Biochem       Date:  1970-04

4.  Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum.

Authors:  S R Holmberg; A J Williams
Journal:  Circ Res       Date:  1990-08       Impact factor: 17.367

5.  Functional characterisation of the ryanodine receptor purified from sheep cardiac muscle sarcoplasmic reticulum.

Authors:  A R Lindsay; A J Williams
Journal:  Biochim Biophys Acta       Date:  1991-04-26

Review 6.  Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel.

Authors:  G Meissner; A el-Hashem
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

7.  Differential activating and deactivating effects of natural ryanodine congeners on the calcium release channel of sarcoplasmic reticulum: evidence for separation of effects at functionally distinct sites.

Authors:  R A Humerickhouse; H R Besch; K Gerzon; L Ruest; J L Sutko; J T Emmick
Journal:  Mol Pharmacol       Date:  1993-08       Impact factor: 4.436

8.  Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca(2+)-release channel.

Authors:  K Gerzon; R A Humerickhouse; H R Besch; K R Bidasee; J T Emmick; R W Roeske; Z Tian; L Ruest; J L Sutko
Journal:  J Med Chem       Date:  1993-05-14       Impact factor: 7.446

9.  Bioactive ryanoids from nucleophilic additions to 4,12-seco-4,12-dioxoryanodine.

Authors:  P R Jefferies; E Lehmberg; W W Lam; J E Casida
Journal:  J Med Chem       Date:  1993-04-30       Impact factor: 7.446

10.  [3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermia.

Authors:  M J Hawkes; T E Nelson; S L Hamilton
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

View more
  13 in total

1.  Localization of an NH(2)-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor.

Authors:  Ruiwu Wang; Wenqian Chen; Shitian Cai; Jing Zhang; Jeff Bolstad; Terence Wagenknecht; Zheng Liu; S R Wayne Chen
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

2.  The interaction of a neutral ryanoid with the ryanodine receptor channel provides insights into the mechanisms by which ryanoid binding is modulated by voltage.

Authors:  B Tanna; W Welch; L Ruest; J L Sutko; A J Williams
Journal:  J Gen Physiol       Date:  2000-07-01       Impact factor: 4.086

3.  Ryanodine-induced structural alterations in the RyR channel suggested by neomycin block.

Authors:  Fiona Mead; Alan J Williams
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

4.  Block of the ryanodine receptor channel by neomycin is relieved at high holding potentials.

Authors:  Fiona Mead; Alan J Williams
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

5.  Voltage-sensitive equilibrium between two states within a ryanoid-modified conductance state of the ryanodine receptor channel.

Authors:  Bhavna Tanna; William Welch; Luc Ruest; John L Sutko; Alan J Williams
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

6.  Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine.

Authors:  J D Fessenden; L Chen; Y Wang; C Paolini; C Franzini-Armstrong; P D Allen; I N Pessah
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Ryanoid modification of the cardiac muscle ryanodine receptor channel results in relocation of the tetraethylammonium binding site.

Authors:  B Tanna; W Welch; L Ruest; J L Sutko; A J Williams
Journal:  J Gen Physiol       Date:  2001-05       Impact factor: 4.086

8.  An anionic ryanoid, 10-O-succinoylryanodol, provides insights into the mechanisms governing the interaction of ryanoids and the subsequent altered function of ryanodine-receptor channels.

Authors:  Bhavna Tanna; William Welch; Luc Ruest; John L Sutko; Alan J Williams
Journal:  J Gen Physiol       Date:  2003-05-12       Impact factor: 4.086

9.  Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release.

Authors:  Nagesh Chopra; Derek Laver; Sean S Davies; Björn C Knollmann
Journal:  Mol Pharmacol       Date:  2008-10-09       Impact factor: 4.436

10.  Ca2+-calmodulin increases RyR2 open probability yet reduces ryanoid association with RyR2.

Authors:  Charalambos Sigalas; Maria Belen Mayo-Martin; David E Jane; Rebecca Sitsapesan
Journal:  Biophys J       Date:  2009-10-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.